Performance characteristics of consensus approaches for small and minor paroxysmal nocturnal hemoglobinuria clone determination by flow cytometry
-
Iuri Marinov
,
Martina Kohoutová
Abstract
Background: Evaluation of paroxysmal nocturnal hemoglobinuria (PNH) clones by flow cytometry (FCM) is not standardized and is associated with consistent inter-laboratory variability.
Methods: In order to rule out the influence of particular approach in generating final results, we analyzed the performance characteristics of individual consensus strategies for small to intermediate (1%–20%) and minor (<1%) PNH clones within the white blood cell (WBC) and red blood cell (RBC) compartments with sensitivity up to 0.1%.
Results: Coefficient of variation (CV) for precision/reproducibility analysis ranged from 0.67%/1.49% to 2.56%/3.09% for granulocytes, from 0.93%/3.09% to 7.76%/12.06% for monocytes and from 0.41%/4.73% to 6.53%/5.1% for RBCs. Coefficient of determination (r2) for linear regression analysis ranged from 0.95 to 0.99, Wilcoxon ranks test showed no statistically significant differences (p>0.05), Bland-Altman analysis demonstrated performance agreement with mean bias ranging from −0.18 to 1.24.
Conclusions: Our results confirmed very good performance characteristics for precision and reproducibility analysis, excellent correlation and favorable agreement between strategies, suggesting that reported inter-laboratory variability is related mainly to incorrect performance and/or insufficient experience with PNH testing by flow cytometry, rather than to relevant limitations of any particular approach.
References
1. van der Schoot CE, Huizinga TW, van’t Veer-Korthof ET, Wijmans R, Pinkster J, von dem Borne AE. Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay. Blood 1990;76:1853–9.10.1182/blood.V76.9.1853.1853Suche in Google Scholar
2. Richards SJ, Rawstron AC, Hillmen P. Application of flow cytometry to the diagnosis of paroxysmal nocturnal hemoglobinuria. Cytometry Part B (Clin Cytom) 2000; 42:223–33.10.1002/1097-0320(20000815)42:4<223::AID-CYTO2>3.0.CO;2-DSuche in Google Scholar
3. Oltenao H, Karandikar NJ, McKenna RW, Xu Y. Differential usefulness of various markers in the flow cytometric detection of paroxysmal nocturnal hemoglobinuria in blood and bone marrow. Am J Clin Pathol 2006;126:781–8.10.1309/AT9Y6WR03PX1K228Suche in Google Scholar
4. Sutherland DR, Kuek N, Davidson J, Barth D, Chang C, Yeo EL, et al. Diagnosing PNH with FLAER and multiparameter flow cytometry. Cytometry Part B (Clin Cytom)2007;72B: 167–77.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000246061000002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1002/cyto.b.20151Suche in Google Scholar
5. Oni SB, Osunkoya BO, Luzzatto L. Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells. Blood 1970;36:145–52.10.1182/blood.V36.2.145.145Suche in Google Scholar
6. Moyo VM, Mukhina GL, Garrett ES, Brodsky RA. Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol 2004;126:133–8.10.1111/j.1365-2141.2004.04992.xSuche in Google Scholar
7. Bessler M, Mason PJ, Hillmen P, Miyata T, Yamada N, Takeda N, et al. Paroxysmal nocturnal hemoglobinuria (PNH) is caused by somatic mutations in the PIG-A gene. EMBO J 1994;13: 110–7.10.1002/j.1460-2075.1994.tb06240.xSuche in Google Scholar
8. Nafa K, Bessler M, Castro-Malaspina H, Jhanwar S, Luzzatto L. The spectrum of somatic mutations in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications. Blood Cells Mol Dis 1998;24:370–84.10.1006/bcmd.1998.0203Suche in Google Scholar
9. Hill A, Hillmen P, Richards SJ, Elebute D, Marsh JC, Chan J, et al. Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria. Blood 2005;106: 2559–65.10.1182/blood-2005-02-0564Suche in Google Scholar
10. Hillmen P, Muus P, Duhrsen U, Risitano AM, Schubert J, Luzzatto L, et al. Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 2007;110:4123–8.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000251272200047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1182/blood-2007-06-095646Suche in Google Scholar
11. Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobuniria. N Engl J Med 2006; 355:1233–43.10.1056/NEJMoa061648Suche in Google Scholar PubMed
12. Wang SA, Pozdnyakova O, Jorgensen JL, Medeiros LJ, Stachurski D, Anderson M, et al. Detection of paroxysmal nocturnal hemoglobinuria clones in patients with myelodysplastic syndromes and related bone marrow diseases, with emphasis on diagnostic pitfalls and caveats. Haematologica 2009;94:29–37.10.3324/haematol.13601Suche in Google Scholar PubMed PubMed Central
13. Galili N, Ravandi F, Palermo G, Bubis J, Illingworth A, Castro-Malaspina H, et al. Prevalence of paroxysmal nocturnal hemoglobinuria (PNH) cells in patients with myelodysplastic syndrome (MDS) aplastic anemia (AA) or other bone marrow failure (BMF)snydromes: interim results from the explore trial. J Clin Oncol 2009;27:15s.10.1200/jco.2009.27.15_suppl.7082Suche in Google Scholar
14. Movalia MK, Illingworth A. Identification and clinical significance of type II granulocytes among patients with paroxysmal nocturnal hemoglobinuria (PNH) identified using multiparameter high sensitivity flow cytometry. Blood 2009;114:3015 (abstr).10.1182/blood.V114.22.3015.3015Suche in Google Scholar
15. Borowitz MJ, Craig FE, DiGiuseppe JA, Illingworth AJ, Rosse W, Sutherland DR, et al. On behalf of the Clinical Cytometry Society. Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry Part B (Clin Cytom) 2010; 78B:211–30.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000279478600001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1002/cyto.b.20525Suche in Google Scholar
16. Sutherland DR, Keeney M, Illingworth A. Practical guidelines for the high-sensitivity detection and monitoring of paroxysmal nocturnal hemoglobinuria clones by flow cytometry. Cytometry Part B (Clin Cytom) 2012;82B(4):195–208.10.1002/cyto.b.21023http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000305556900035&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Suche in Google Scholar PubMed
17. Marinov I, Kohoutová M, Tkáčová V, Lysák D, Holubová M, Stehlíková O, et al. Intra- and interlaboratory variability of paroxysmal nocturnal hemoglobinuria testing by flow cytometry following the 2012 practical guidelines for high-sensitivity paroxysmal nocturnal hemoglobinuria testing. Cytometry Part B (Clin Cytom) 2013;000B:000–000.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000320732900005&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Suche in Google Scholar
18. Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, et al. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 2005;106:3699–709.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000254675500002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Suche in Google Scholar
19. Richards SJ, Hill A, Hillmen P. Recent advances in the diagnosis, monitoring and management of patients with paroxysmal nocturnal hemoglobinuria. Cytometry Part B (Clin Cytom) 2007;72B:291–8.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000249104300001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1002/cyto.b.20358Suche in Google Scholar PubMed
20. Sutherland DR, Kuek N, Azcona-Olivera J, Anderson T, Acton E, Barth D, et al. Use of FLAER-based white blood cell assay in the primary screening of PNH clones. Am J Clin Pathol 2009;132:564–72.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000270503500010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f310.1309/AJCPMRDZZFQM7YJ4Suche in Google Scholar PubMed
©2013 by Walter de Gruyter Berlin Boston
Artikel in diesem Heft
- Letter to the Editor
- Elevated level of cell-free plasma DNA is associated with advanced-stage breast cancer and metastasis
- Is procalcitonin a reliable marker of sepsis in critically ill septic patients undergoing continuous veno-venous hemodiafiltration with “high cut-off” membranes (HCO-CVVHDF)?
- Challenging our serological algorithm for celiac disease (CD) diagnosis by the ESPGHAN guidelines
- Preanalytical quality control in a university hospital in China
- Racial differences and relationships between gestational thyrotropin and free thyroxine in a multiracial Asian population
- Analytical performance and method comparison study of the total homocysteine immunoassay on the AIA 600II analyser
- Easy verification of clinical chemistry reference intervals
- The Elecsys® Vitamin B12 assay is not affected by anti-intrinsic factor antibodies
- Chemiluminescence-based cobalamin assay errors: background and perspectives
- Congress Abstracts
- Abstracts IV Italian Great Network Congress Rome, 14th–18th October 2013*)
- Masthead
- Masthead
- Editorial
- Making colorectal cancer screening FITTER for purpose with quantitative faecal immunochemical tests for haemoglobin (FIT)
- From “panic” to “critical” values: which path toward harmonization?
- Review
- Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?
- Opinion Paper
- False myths and legends in laboratory diagnostics
- General Clinical Chemistry and Laboratory Medicine
- National survey on critical values notification of 599 institutions in China
- Influence of physical properties of cuvette surface on measurement of serum lipase
- Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle-cell disease and sickle-cell thalassemia
- Measurement of immature platelets with Abbott CD-Sapphire and Sysmex XE-5000 in haematology and oncology patients
- Performance characteristics of consensus approaches for small and minor paroxysmal nocturnal hemoglobinuria clone determination by flow cytometry
- Comparison of PR3-ANCA specific assay performance for the diagnosis of granulomatosis with polyangiitis (Wegener’s)
- The integration of the detection of systemic sclerosis-associated antibodies in a routine laboratory setting: comparison of different strategies
- Reference Values and Biological Variations
- Reference interval studies: what is the maximum number of samples recommended?
- Short-term estimation and application of biological variation of small dense low-density lipoproteins in healthy individuals
- Cancer Diagnostics
- Diagnostic inconsistency of faecal immunochemical tests for haemoglobin in population screening of colorectal cancer
- Cardiovascular Diseases
- Comparison of the 99th percentiles of three troponin I assays in a large reference population
- Assessment of plasma aminothiol levels and the association with recurrent atherothrombotic events in patients hospitalized for an acute coronary syndrome: a prospective study
- Diabetes
- The relationship between estimated average glucose and fasting plasma glucose
- Evaluation of enzymatic BM Test HbA1c on the JCA-BM6010/C and comparison with Bio-Rad Variant II Turbo, Tosoh HLC 723 G8, and AutoLab immunoturbidimetry assay
Artikel in diesem Heft
- Letter to the Editor
- Elevated level of cell-free plasma DNA is associated with advanced-stage breast cancer and metastasis
- Is procalcitonin a reliable marker of sepsis in critically ill septic patients undergoing continuous veno-venous hemodiafiltration with “high cut-off” membranes (HCO-CVVHDF)?
- Challenging our serological algorithm for celiac disease (CD) diagnosis by the ESPGHAN guidelines
- Preanalytical quality control in a university hospital in China
- Racial differences and relationships between gestational thyrotropin and free thyroxine in a multiracial Asian population
- Analytical performance and method comparison study of the total homocysteine immunoassay on the AIA 600II analyser
- Easy verification of clinical chemistry reference intervals
- The Elecsys® Vitamin B12 assay is not affected by anti-intrinsic factor antibodies
- Chemiluminescence-based cobalamin assay errors: background and perspectives
- Congress Abstracts
- Abstracts IV Italian Great Network Congress Rome, 14th–18th October 2013*)
- Masthead
- Masthead
- Editorial
- Making colorectal cancer screening FITTER for purpose with quantitative faecal immunochemical tests for haemoglobin (FIT)
- From “panic” to “critical” values: which path toward harmonization?
- Review
- Cerebrospinal fluid analyses for the diagnosis of subarachnoid haemorrhage and experience from a Swedish study. What method is preferable when diagnosing a subarachnoid haemorrhage?
- Opinion Paper
- False myths and legends in laboratory diagnostics
- General Clinical Chemistry and Laboratory Medicine
- National survey on critical values notification of 599 institutions in China
- Influence of physical properties of cuvette surface on measurement of serum lipase
- Red cell indices: differentiation between β-thalassemia trait and iron deficiency anemia and application to sickle-cell disease and sickle-cell thalassemia
- Measurement of immature platelets with Abbott CD-Sapphire and Sysmex XE-5000 in haematology and oncology patients
- Performance characteristics of consensus approaches for small and minor paroxysmal nocturnal hemoglobinuria clone determination by flow cytometry
- Comparison of PR3-ANCA specific assay performance for the diagnosis of granulomatosis with polyangiitis (Wegener’s)
- The integration of the detection of systemic sclerosis-associated antibodies in a routine laboratory setting: comparison of different strategies
- Reference Values and Biological Variations
- Reference interval studies: what is the maximum number of samples recommended?
- Short-term estimation and application of biological variation of small dense low-density lipoproteins in healthy individuals
- Cancer Diagnostics
- Diagnostic inconsistency of faecal immunochemical tests for haemoglobin in population screening of colorectal cancer
- Cardiovascular Diseases
- Comparison of the 99th percentiles of three troponin I assays in a large reference population
- Assessment of plasma aminothiol levels and the association with recurrent atherothrombotic events in patients hospitalized for an acute coronary syndrome: a prospective study
- Diabetes
- The relationship between estimated average glucose and fasting plasma glucose
- Evaluation of enzymatic BM Test HbA1c on the JCA-BM6010/C and comparison with Bio-Rad Variant II Turbo, Tosoh HLC 723 G8, and AutoLab immunoturbidimetry assay
